Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

NCT07383441 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

718

Enrollment

NETWORK

Sponsor class

Conditions

Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

DRUG: Axitinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Cabozantinib
DRUG: Clostridium butyricum CBM 588 Probiotic Strain
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
DRUG: Lenvatinib
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
DRUG: Nivolumab and Recombinant Human Hyaluronidase
BIOLOGICAL: Pembrolizumab
DRUG: Placebo Administration

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]